| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | -0.0072 | 0.9 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | 0.0074 | 0.9 |
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | -0.014 | 0.9 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | -0.02 | 0.9 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | -0.018 | 0.9 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | 0.019 | 0.9 |